189 related articles for article (PubMed ID: 12715665)
1. [Calculated consequences of the Danish treatment of Staphylococcus aureus bacteremia and meningitis 2].
Høiby N; Tvede M
Ugeskr Laeger; 2003 Apr; 165(15):1574. PubMed ID: 12715665
[No Abstract] [Full Text] [Related]
2. [Calculated consequences of the Danish treatment of Staphylococcus aureus bacteremia and meningitis 3].
Siboni AH
Ugeskr Laeger; 2003 Apr; 165(15):1574-5. PubMed ID: 12715666
[No Abstract] [Full Text] [Related]
3. [Calculated consequences of the Danish treatment of Staphylococcus aureus bacteremia and meningitis].
Høiby N; Tvede M
Ugeskr Laeger; 2003 Mar; 165(10):1045-6; author reply 1046. PubMed ID: 12645416
[No Abstract] [Full Text] [Related]
4. Haematogenous Staphylococcus aureus meningitis. A 10-year nationwide study of 96 consecutive cases.
Pedersen M; Benfield TL; Skinhoej P; Jensen AG
BMC Infect Dis; 2006 Mar; 6():49. PubMed ID: 16542437
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid penetration of high-dose daptomycin in suspected Staphylococcus aureus meningitis.
Riser MS; Bland CM; Rudisill CN; Bookstaver PB
Ann Pharmacother; 2010 Nov; 44(11):1832-5. PubMed ID: 20959502
[TBL] [Abstract][Full Text] [Related]
6. Positive blood cultures and diagnosis of bacterial meningitis in cases with negative culture of cerebrospinal fluid.
Fuglsang-Damgaard D; Pedersen G; Schønheyder HC
Scand J Infect Dis; 2008; 40(3):229-33. PubMed ID: 17907046
[TBL] [Abstract][Full Text] [Related]
7. Cefazolin therapy for Staphylococcus aureus bacteremia.
Fernández-Guerrero ML; de Górgolas M
Clin Infect Dis; 2005 Jul; 41(1):127. PubMed ID: 15937778
[No Abstract] [Full Text] [Related]
8. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
Laupland KB; Ross T; Gregson DB
J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
[TBL] [Abstract][Full Text] [Related]
9. [Antibiotic resistant S aureus--increased mortality and more expensive health care].
Melander E; Burman LG; Cars O
Lakartidningen; 2007 Oct 17-23; 104(42):3052-6. PubMed ID: 17985713
[No Abstract] [Full Text] [Related]
10. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML
Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of methicillin-resistant staphylococcus aureus meningitis with daptomycin.
Lee DH; Palermo B; Chowdhury M
Clin Infect Dis; 2008 Aug; 47(4):588-90. PubMed ID: 18636964
[No Abstract] [Full Text] [Related]
12. [Initial treatment of purulent meningitis in adults].
Bangsborg JM; Jarløv JO; Baek L
Ugeskr Laeger; 2003 Apr; 165(15):1575; author reply 1575. PubMed ID: 12715667
[No Abstract] [Full Text] [Related]
13. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
Trials; 2019 May; 20(1):250. PubMed ID: 31046810
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus meningitis: experience with cefuroxime treatment during a 16 year period in a Danish region.
Nørgaard M; Gudmundsdottir G; Larsen CS; Schønheyder HC
Scand J Infect Dis; 2003; 35(5):311-4. PubMed ID: 12875516
[TBL] [Abstract][Full Text] [Related]
15. Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid.
Kessler AT; Kourtis AP
Infection; 2007 Jun; 35(4):271-4. PubMed ID: 17646913
[TBL] [Abstract][Full Text] [Related]
16. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.
Kim SH; Park WB; Lee KD; Kang CI; Kim HB; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2003 Sep; 37(6):794-9. PubMed ID: 12955640
[TBL] [Abstract][Full Text] [Related]
17. Management of methicillin-resistant Staphylococcus aureus bacteremia.
Cosgrove SE; Fowler VG
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S386-93. PubMed ID: 18462094
[TBL] [Abstract][Full Text] [Related]
18. [Antibiotic sensitivity of S. aureus strains isolated from meningeal infections].
Fedulov D; Mihalache DG
Bacteriol Virusol Parazitol Epidemiol; 2007; 52(3-4):125-8. PubMed ID: 19326725
[No Abstract] [Full Text] [Related]
19. Paradoxical relationship between the clinical outcome of Staphylococcus aureus bacteremia and the minimum inhibitory concentration of vancomycin.
Price J; Atkinson S; Llewelyn M; Paul J
Clin Infect Dis; 2009 Apr; 48(7):997-8. PubMed ID: 19260820
[No Abstract] [Full Text] [Related]
20. Management of persistent bacteremia caused by methicillin-resistant Staphylococcus aureus: a survey of infectious diseases consultants.
Hageman JC; Liedtke LA; Sunenshine RH; Strausbaugh LJ; McDonald LC; Tenover FC;
Clin Infect Dis; 2006 Sep; 43(5):e42-5. PubMed ID: 16886141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
